glp-1 obesity drug news oct 21 2025 Why Non-Responders Need Earlier Anti-Obesity Medication Intervention GlobalRPH New GLP-1 Pill Foundayo (Orforglipron)

Gut hormones and appetite control: a focus on PYY and GLP-1 as therapeutic targets in obesity

A., Aleppo G., Aroda V

Raz I., Hanefeld M., Xu L., et al., Efficacy and Safety of the Dipeptidyl Peptidase4 Inhibitor Sitagliptin as Monotherapy in Patients With Type 2 Diabetes Mellitus, Diabetologia 49 (2006): 25642571

The risk of multiple myeloma was 41% lower in those taking GLP-1 drugs compared to insulin

For most retatrutide vials, adding 1ml of bacteriostatic water to a 5mg vial produces a concentration of 5mg/ml, making dose measurement straightforward

Global, Regional, and National Prevalence of Overweight and Obesity in Children and Adults during 19802013: A Systematic Analysis for the Global Burden of Disease Study 2013